# OnCo record paper-krystal-1-adagrasib-kras-g12c-solid-tumours-jco-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-krystal-1-adagrasib-kras-g12c-solid-tumours-jco-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-krystal-1-adagrasib-kras-g12c-solid-tumours-jco-2023" ;
  schema:name "KRYSTAL-1: adagrasib in advanced solid tumours harbouring a KRAS G12C mutation, including pancreatic cancer"@en ;
  schema:description "Adagrasib, the second KRAS G12C pill, shrank tumours in about a third of patients with pancreatic cancer and in two in five with bile duct cancer in this basket study, with disease control for several months."@en ;
  schema:url <https://onco.cc/key-papers/paper-krystal-1-adagrasib-kras-g12c-solid-tumours-jco-2023/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.23.00434>, <https://pubmed.ncbi.nlm.nih.gov/37099736/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.23.00434> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Bekaii-Saab TS, Yaeger R, Spira AI, et al." ;
  onco:cancers <https://onco.cc/cancers/kras-g12c-pdac/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/adagrasib/> ;
  onco:trials <https://onco.cc/trials/nct03785249/> ;
  onco:journals <https://onco.cc/journals/jco/> .